نتائج البحث

Development and evaluation of uncertainty quantifying machine learning models to predict piperacillin plasma concentrations in critically ill patients.

• Authors : Verhaeghe J; IDLab, Department of Information Technology, Ghent University - imec, Ghent, Belgium. .; Dhaese SAM

Subjects: Critical Illness* ; Piperacillin*/Piperacillin*/Piperacillin*/pharmacokinetics ; Piperacillin*/Piperacillin*/Piperacillin*/therapeutic use

• Source: BMC medical informatics and decision making [BMC Med Inform Decis Mak] 2022 Aug 25; Vol. 22 (1), pp. 224. Date of Electronic Publication: 2022 Aug 25.Publisher: BioMed Central Country of Publication: England NLM ID: 101088682 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6947

تفاصيل العنوان

Pharmacokinetics of piperacillin and tazobactam in critically Ill patients treated with continuous kidney replacement therapy: A mini-review and population pharmacokinetic analysis.

• Authors : Selig DJ; Walter Reed Army Institute of Research, Experimental Therapeutics, Silver Spring, Maryland, USA.; DeLuca JP

Subjects: Critical Illness*/Critical Illness*/Critical Illness*/therapy ; Piperacillin*; Anti-Bacterial Agents

• Source: Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2022 Aug; Vol. 47 (8), pp. 1091-1102. Date of Electronic Publication: 2022 Mar 29.Publisher: Country of Publication: England NLM ID: 8704308 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2710

تفاصيل العنوان

Extended infusion of piperacillin-tazobactam versus intermittent infusion in critically ill egyptian patients: a cost-effectiveness study.

• Authors : Naiim CM; Clinical Pharmacy Department, Faculty of Pharmacy, The British University in Egypt (BUE) Cairo, P.O.BOX 43, Cairo, 11837, Egypt. .; Elmazar MM

Subjects: Gram-Negative Bacterial Infections*/Gram-Negative Bacterial Infections*/Gram-Negative Bacterial Infections*/microbiology ; Piperacillin*/Piperacillin*/Piperacillin*/therapeutic use; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/therapeutic use

• Source: Scientific reports [Sci Rep] 2022 Jun 27; Vol. 12 (1), pp. 10882. Date of Electronic Publication: 2022 Jun 27.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

PipEracillin Tazobactam Versus MERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN) (PETERPEN)

• Authors : Rabin Medical Center; University of Modena and Reggio Emilia; Tel Aviv Medical Center

• Source: Piperacillin Tazobactam Versus Meropenem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae- a Non-inferiority Randomized

تفاصيل العنوان

PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock (PAACS)

• Source: Pharmacokinetics and Pharmacodynamic (PK/PD) of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic ShockTaccone FS,

تفاصيل العنوان

Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?

• Authors : Indiana University; Massachusetts General Hospital; Thomas Jefferson University

• Source: A Phase III Multicenter, Open Label Randomized Controlled Trial of Cefoxitin Versus Piperacillin-Tazobactam as Surgical Antibiotic Prophylaxis in Patients Undergoing

تفاصيل العنوان

Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin-Tazobactam for the Population with Obesity

• Authors : Benoit Crevier, Principal Investigator

• Source: Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin-Tazobactam for the Population with Obesity: an Open Randomized Controlled Feasibility Study

تفاصيل العنوان

Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae (CAPITIS)

• Source: Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic Urinary Tract Infections Due to Extended-spectrum Β-lactamase (ESBL)-producing Escherichia Coli or

تفاصيل العنوان

Analysis of IV Drugs in the Hospital Workflow by Raman Spectroscopy: The Case of Piperacillin and Tazobactam.

• Authors : Chrisikou I; Department of Pharmacy, University of Patras, University Campus, GR-26504 Rio Achaias, Greece.; Institute of Chemical Engineering Sciences, Foundation of Research and Technology-Hellas (ICE-HT/FORTH), GR-26504 Platani Achaias, Greece.

Subjects: Workflow*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Hospitals/Hospitals/Hospitals/*standards

• Source: Molecules (Basel, Switzerland) [Molecules] 2021 Sep 28; Vol. 26 (19). Date of Electronic Publication: 2021 Sep 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers. (PROBATAZO)

• Source: Antimicrobial Therapy for Ventilator-associated Pneumonia Among Patients Colonized With Extended-spectrum Beta-lactamase-producing Enterobacteriaceae : Efficacy of a Strategy Using

تفاصيل العنوان